Skip to content

Clinical trials

Lipid Metabolism Disorders trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lipid Metabolism Disorders Country / region: Canada Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20071
20081
20132
20141
20151
20161
20173
20181
20201
20223
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Akcea Therapeutics2
Kastle Therapeutics, LLC2
Université de Sherbrooke2
89bio, Inc.1
Alexion Pharmaceuticals, Inc.1
Eli Lilly and Company1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
NewAmsterdam Pharma1
Pfizer1
Shire1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lipid Metabolism Disorders18
Metabolic Diseases13
Dyslipidemias8
Genetic Diseases, Inborn7
Hyperlipidemias7
Hyperlipoproteinemias6
Metabolism, Inborn Errors6
Lipid Metabolism, Inborn Errors5
Hypercholesterolemia4
Hyperlipoproteinemia Type II4

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.